Ambrx Biopharma Inc.

NYSE:AMAM

28 (USD) • At close March 6, 2024
Bedrijfsnaam Ambrx Biopharma Inc.
Symbool AMAM
Munteenheid USD
Prijs 28
Beurswaarde 1,772,097,600
Dividendpercentage 0%
52-weken bereik 6.55 - 28.15
Industrie Biotechnology
Sector Healthcare
CEO Mr. Daniel J. O'Connor J.D.
Website https://ambrx.com

An error occurred while fetching data.

Over Ambrx Biopharma Inc.

Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gastric/gastroesophageal junction cancer, and other

Vergelijkbare Aandelen

Sonida Senior Living, Inc. logo

Sonida Senior Living, Inc.

SNDA

23.7 USD

Enzo Biochem, Inc. logo

Enzo Biochem, Inc.

ENZ

0.763 USD

Vapotherm, Inc. logo

Vapotherm, Inc.

VAPO

2.17 USD

Annovis Bio, Inc. logo

Annovis Bio, Inc.

ANVS

4.37 USD

Sonendo, Inc. logo

Sonendo, Inc.

SONX

1.92 USD

Rafael Holdings, Inc. logo

Rafael Holdings, Inc.

RFL

1.95 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)